Sign in

CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company

ORAMED PHARMACEUTICALS INC.

Sign in to watch
Ticker
ORMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980376008
Phone
646-844-1164
Business address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Former names
Integrated Security Technologies, Inc., IGUANA VENTURES LTD
  1. 4 Grant or award Director acquired 36,510 shares (grant or award)
  2. 4 Grant or award Director acquired 34,650 shares (grant or award)
  3. 4 Grant or award Chief Scientific Officer acquired 192,667 shares (grant or award)
  4. 4 Grant or award COO & CBO acquired 126,834 shares (grant or award)
  5. 4 Grant or award President and CEO acquired 427,000 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 76,000 shares (grant or award)
  7. 4 Grant or award President and CEO acquired 433,500 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 188,000 shares (grant or award)
  9. 4 Grant or award Chief Scientific Officer acquired 207,000 shares (grant or award)
  10. 4 Grant or award COO & CBO acquired 194,500 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
  12. 4 Grant or award President and CEO acquired 45,000 shares (grant or award)
  13. 4 Grant or award Chief Scientific Officer acquired 30,000 shares (grant or award)
  14. 4 Grant or award COO & CBO acquired 30,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 140,040 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 760 shares (grant or award)
  18. 4 Grant or award Director acquired 29,800 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award Director acquired 3,750 shares (grant or award)

Page 3 of 16 · 306 filings